HomeCompareCRKR vs JNJ

CRKR vs JNJ: Dividend Comparison 2026

CRKR yields 388.35% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRKR wins by $9219.96M in total portfolio value
10 years
CRKR
CRKR
● Live price
388.35%
Share price
$0.52
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9219.98M
Annual income
$6,119,965,813.94
Full CRKR calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CRKR vs JNJ

📍 CRKR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRKRJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRKR + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRKR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRKR
Annual income on $10K today (after 15% tax)
$33,009.71/yr
After 10yr DRIP, annual income (after tax)
$5,201,970,941.85/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CRKR beats the other by $5,201,970,238.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRKR + JNJ for your $10,000?

CRKR: 50%JNJ: 50%
100% JNJ50/50100% CRKR
Portfolio after 10yr
$4610.00M
Annual income
$3,059,983,320.86/yr
Blended yield
66.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CRKR
No analyst data
Altman Z
-2.8
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRKR buys
0
JNJ buys
0
No recent congressional trades found for CRKR or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRKRJNJ
Forward yield388.35%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$9219.98M$20.0K
Annual income after 10y$6,119,965,813.94$827.78
Total dividends collected$8932.39M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CRKR vs JNJ ($10,000, DRIP)

YearCRKR PortfolioCRKR Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$49,535$38,834.95$10,676$355.77+$38.9KCRKR
2$232,786$179,783.87$11,407$389.39+$221.4KCRKR
3$1,038,691$789,609.88$12,198$426.53+$1.03MCRKR
4$4,404,143$3,292,743.35$13,056$467.62+$4.39MCRKR
5$17,760,587$13,048,153.59$13,987$513.12+$17.75MCRKR
6$68,180,731$49,176,903.78$14,998$563.56+$68.17MCRKR
7$249,387,170$176,433,787.00$16,098$619.52+$249.37MCRKR
8$869,973,574$603,129,302.77$17,295$681.69+$869.96MCRKR
9$2,897,211,689$1,966,339,964.68$18,599$750.82+$2897.19MCRKR
10$9,219,982,321$6,119,965,813.94$20,022$827.78+$9219.96MCRKR

CRKR vs JNJ: Complete Analysis 2026

CRKRStock

Creek Road Miners, Inc. engages in cryptocurrency mining business. The company was formerly known as Wizard Brands, Inc. and changed its name to Creek Road Miners, Inc. in July 2021. The company was incorporated in 2001 and is based in Park City, Utah.

Full CRKR Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CRKR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRKR vs SCHDCRKR vs JEPICRKR vs OCRKR vs KOCRKR vs MAINCRKR vs ABBVCRKR vs MRKCRKR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.